Results
Beta Drugs Limited Q2 H1 FY27 Earnings Conference Call
Beta Drugs reported H1 FY27 revenue growth of 29.2% YoY and a 45% YoY PAT increase to INR34 crores, with EBITDA margins stable at 23.18%.
Management guided for sustained 20-25% growth over the next 3-
